- Home
- CMAX vs SHPH Comparison
CMAX vs SHPH Comparison
Compare CMAX & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMAX
- SHPH
- Stock Information
- Founded
- CMAX 2011
- SHPH 2012
- Country
- CMAX United States
- SHPH United States
- Employees
- CMAX N/A
- SHPH N/A
- Industry
- CMAX Computer Software: Prepackaged Software
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- CMAX Technology
- SHPH Health Care
- Exchange
- CMAX Nasdaq
- SHPH Nasdaq
- Market Cap
- CMAX 7.6M
- SHPH 3.3M
- IPO Year
- CMAX N/A
- SHPH 2022
- Fundamental
- Price
- CMAX $1.85
- SHPH $1.29
- Analyst Decision
- CMAX Hold
- SHPH
- Analyst Count
- CMAX 2
- SHPH 0
- Target Price
- CMAX $33.20
- SHPH N/A
- AVG Volume (30 Days)
- CMAX 58.0K
- SHPH 42.2K
- Earning Date
- CMAX 11-07-2024
- SHPH 11-12-2024
- Dividend Yield
- CMAX N/A
- SHPH N/A
- EPS Growth
- CMAX N/A
- SHPH N/A
- EPS
- CMAX N/A
- SHPH N/A
- Revenue
- CMAX $784,551,000.00
- SHPH N/A
- Revenue This Year
- CMAX $13.01
- SHPH N/A
- Revenue Next Year
- CMAX $32.42
- SHPH N/A
- P/E Ratio
- CMAX N/A
- SHPH N/A
- Revenue Growth
- CMAX 9.06
- SHPH N/A
- 52 Week Low
- CMAX $1.55
- SHPH $1.03
- 52 Week High
- CMAX $74.70
- SHPH $4.96
- Technical
- Relative Strength Index (RSI)
- CMAX 46.01
- SHPH 46.55
- Support Level
- CMAX $1.60
- SHPH $1.12
- Resistance Level
- CMAX $2.39
- SHPH $1.26
- Average True Range (ATR)
- CMAX 0.19
- SHPH 0.11
- MACD
- CMAX 0.07
- SHPH 0.05
- Stochastic Oscillator
- CMAX 32.50
- SHPH 59.09
About CMAX CareMax Inc.
CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.